Controlled Trial of Azathioprine and Plasma Exchange in Addition to Prednisolone in the Treatment of Bullous Pemphigoid

Archives of Dermatology

Volumn 129, Issue 1, 1993, Pages 49-53

  Guillaume, Jean Claude ^a   Vaillant, Loïc ^b   Bernard, Philippe ^c   Picard, Catherine ^d   Prost, Catherine ^a   Labeille, Bruno ^e   Guillot, Bernard ^f   Foldès Pauwels, Christine ^g   Prigent, François ^h   Joly, Pascal ⁱ   Cordoliani, Florence ^j   Salagnac, Véronique ^k   Machet, Laurent ^b   Aldigier, Jean Claude ^c   Crickx, Béatrice ^d   Roujeau, Jean Claude ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c DUPUYTREN UNIVERSITY HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f Hopital Saint Charles   (France)

^g CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^h Hôpital de Saint Cloud   (France)

ⁱ HÔPITAL CHARLES NICOLLE   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k Hopital Sebastopol   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISOLONE 3 SULFOBENZOATE;

AGED; ARTICLE; BLISTER; BLOOD TOXICITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG FATALITY; EROSION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PEMPHIGOID; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION;

AGED; AZATHIOPRINE; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; PEMPHIGOID, BULLOUS; PLASMA EXCHANGE; PREDNISOLONE; SUPPORT, NON-U.S. GOV'T;

EID: 0027475229     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1993.01680220061016     Document Type: Article

References (24)

1. 1. Morrison LH, Diaz LA, Anhalt GJ. Bullous pemphigoid. In: Wojnarowska F, Briggaman RA, eds. Management of Blistering Diseases. London, England: Chapman & Hall; 1990: 63-82.
2. 2. Robledo MA, Kim SC, Korman NJ, et al. Studies of the relationship of the 230-kd and 180-kd bullous pemphigoid antigens. J Invest Dermatol. 1990; 94: 793-797.
3. 3. Dubertret L, Bertaux B, Fosse M, Touraine R. Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol. 1980; 103: 615-623.
4. 4. Sams WM, Gammon WR. Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol. 1982; 6: 431-449.
5. 5. Ahmed AR. Bullous pemphigoid. Clin Dermatol. 1987; 5: 1-170.
6. 6. Morel P, Guillaume J-C. Traitement de la pemphigoide bulleuse par la prednisolone seule: 0.75 mg/kg/j contre 1.25 mg/kg/j:étude randomisée multicentrique. Ann Dermatol Venereol. 1984; 111: 925-928.
7. 7. Savin JA. Some factors affecting prognosis in pemphigus vulgaris and pemphigoid. Br J Dermatol. 1981; 104: 415-420.
8. 8. Bernard P, Venot J, Rommel A, Bonnetblanc JM, Texier L. Pemphigoide bulleuse: étude du pronostic à propos de cinquante-sept observations. Sem Hop (Paris). 1986; 62: 1229-1232.
9. 9. Person JR, Rogers RS. Bullous pemphigoid responding to sulfapyridine and sulfones. Arch Dermatol. 1977; 113: 610-615.
10. 10. Fox BJ, Odom RB, Findlay RF. Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. J Am Acad Dermatol. 1982; 4: 504-510.
11. 11. Berk MA, Lorincz AL. The treatment of bullous pemphigoid with tetracycline and niacinamide. Arch Dermatol. 1986; 122: 670-674.
12. 12. Greaves MW, Burton JL, Marks J. Azathioprine in the treatment of bullous pemphigoid. BMJ. 1971; 1: 144-145.
13. 13. Krain LS, Landav JW, Newcomer VD. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. Arch Dermatol. 1972; 106: 657-661.
14. 14. Milligan A, Hutchinson PE. The use of chlorambucil in the treatment of bullous pemphigoid. J Am Acad Dermatol. 1990; 22: 796-801.
15. 15. Thivolet J, Barthelemy H, Rigot-Muller G, Bendelac A. Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet. 1985; 1: 334-335.
16. 16. Godard W, Roujeau J-C, Guillot B, André C, Rifle G. Bullous pemphigoid and intravenous gammaglobulins. Ann Intern Med. 1986; 83: 965.
17. 17. Roujeau J-C, Guillaume J-C, Morel P, et al. Plasma exchange in bullous pemphigoid. Lancet. 1984; 2: 486-489.
18. 18. Guillot B, Donadio D, Guilhou J-J, Meynadier J. Long-term plasma exchange therapy in bullous pemphigoid. Acta Derm Venereol (Stockh). 1986; 66: 73-75.
19. 19. Burton JL, Harman RMM, Peachey RDG, Warin RP. Azathioprine plus prednisone in treatment of pemphigoid. BMJ. 1978; 2: 1190-1191.
20. 20. Bystryn J-C. Adjuvant therapy of pemphigus. Arch Dermatol. 1984; 120: 941-951.
21. 21. Guillaume J-C, Roujeau J-C, Morel P, et al. Controlled study of plasma exchange in pemphigus. Arch Dermatol. 1988; 124: 1659-1663.
22. 22. Guillaume J-C, Roujeau J-C, Touzet C, Revuz J, Touraine R. Traitement de la pemphigoide bulleuse par échanges plasmatiques et prednisolone. Nouv Presse Med. 1985; 14: 1139-1142.
23. 23. Westerhof W. Treatment of bullous pemphigoid with topical clobetasol propionate. J Am Acad Dermatol. 1989; 20: 458-461.
24. 24. Venning VA, Millard PR, Wojnarowska F. Dapsone as first line therapy for bullous pemphigoid. Br J Dermatol. 1989; 120: 83-92.